Table 1.
Laboratory results during treatment
| Variables | D1 | D2 | D3 | D4 | D5 | D6 | D7 | D9 | D12 | D13 | D14 | D15 | D16 | D18 | D20 | D24 |
| Hb (g/dL) | 11.1 | 3.8 | 6.6 | 6.9 | 10.4 | 11.1 | 10.7 | 9.1 | 9.3 | 8.7 | 8.5 | 9.2 | 10.0 | |||
| Hct (%) | 31.2 | 10.9 | 18.7 | 20.1 | 31.8 | 34.5 | 32.5 | 27.2 | 28.1 | 25.9 | 25.0 | 27.3 | 29.7 | |||
| PLT (109/L) | 374 | 83 | 94 | 208 | 318 | 434 | 480 | 445 | 767 | 680 | 695 | 417 | 429 | |||
| WBC (109/L) | 10.260 | 14.360 | 8.550 | 9.560 | 14.190 | 23.390 | 24.900 | 17.690 | 17.060 | 16.300 | 16.740 | 10.32 | 11.72 | |||
| NLR | 21.5 | 4.91 | 19.9 | 4.96 | 4.7 | 9.1 | ||||||||||
| PT/APTT (s) | 10.2/30.5 | 12.2/24.3 | 14.7/30.2 | 16.2/31.2 | 14/26.7 | |||||||||||
| RBG (mg/dL) | 81 | |||||||||||||||
| AST/ALT (U/L) | 20/12 | 31/9 | 33/7 | 41/13 | 20/16 | |||||||||||
| BUN/SC (mg/dL; U/L) | 5.1/0.69 | 19/2.81 | 33.1/3.94 | 34.4/3.66 | 52.9/4.24 | 50.2/2.84 | 47.7/1.6 | 9.6/0.62 | 10.3/0.76 | |||||||
| Albumin (mg/dL) | 3.29 | 2.91 | 2.95 | 2.95 | 3.2 | 3.32 | 3.15 | 3.28 | ||||||||
| Na/K/Cl | 138/3.2/105 | 127/3.1/102 | 128/3.2/103 | 131/3.6/103 | 143/3.5/107 | 136/3.3/105 | 133/3.1/105 | 134/2.9/102 | 133/3.6/103 | |||||||
| Ca/Mg (mg/dL) | 6.9/2.33 | 7.8/2.08 | 9.1/0.89 | |||||||||||||
| Fibrinogen/D-dimer (mg/dL; µg/mL) | 410.6 | 614.2/14.05 | - /17.46 | -/3.8 | ||||||||||||
| Procalcitonin (ng/mL) | 9.5 | 0.29 | 6.05 | 0.09 | ||||||||||||
| IgG/IgM | +/− | +/+ | ||||||||||||||
| RT-PCR | Negative | Negative | Positive | Negative | Negative |
ALT, alanine transaminase; ALT, aspartate transaminase; APTT, activated partial thromboplastin time; BUN, blood urea nitrogen; Hb, haemoglobin; Hct, haematocrit; NLR, neutrophil–lymphocyte ratio; PCT, platelet count; PT, partial thromboplastin time; RBG, random blood glucose; RT-PCR, reverse transcription PCR; SC, serum creatinine; WBC, white blood cells.